Attached files
| file | filename |
|---|---|
| 10-K - 10-K 12.31.16 - CALADRIUS BIOSCIENCES, INC. | clbs-10kx20161231.htm |
| EX-32 - EXHIBIT 32 - CALADRIUS BIOSCIENCES, INC. | clbs-ex32_20161231.htm |
| EX-31.2 - EXHIBIT 31.2 - CALADRIUS BIOSCIENCES, INC. | clbs-ex312_20161231xq4.htm |
| EX-31.1 - EXHIBIT 31.1 - CALADRIUS BIOSCIENCES, INC. | clbs-ex311_20161231xq4.htm |
| EX-21.1 - EXHIBIT 21.1 SUBSIDIARIES - CALADRIUS BIOSCIENCES, INC. | exh2112016.htm |
| EX-10.8 - EXHIBIT 10.8 DIRECTOR COMP POLICY - CALADRIUS BIOSCIENCES, INC. | exh1015directorcomppolicy.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 16, 2017, with respect to the consolidated financial statements included in the Annual Report of Caladrius Biosciences, Inc. on Form 10-K for the year ended December 31, 2016. We consent to the incorporation by reference of said report in the Registration Statements of Caladrius Biosciences, Inc. on Forms S-3 (File No. 333-196702, File No. 333-206175, File No. 333-210664 and 333-214607) and on Forms S-8 (File No. 333-107438, File No. 333-144265, File No. 333-159282, File No. 333-162733, File No. 333-173854, File No. 333-181365, File No. 333- 184927, File No. 333-191572, File No. 333-205662, File No. 333-212202 and File No. 333-215455).
/s/ GRANT THORNTON LLP
New York, New York
March 16, 2017